1
|
Ni T, Hao Y, Ding Z, Chi X, Xie F, Wang R, Bao J, Yan L, Li L, Wang T, Zhang D, Jiang Y. Discovery of a Novel Potent Tetrazole Antifungal Candidate with High Selectivity and Broad Spectrum. J Med Chem 2024; 67:6238-6252. [PMID: 38598688 DOI: 10.1021/acs.jmedchem.3c02188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/12/2024]
Abstract
Thirty-one novel albaconazole derivatives were designed and synthesized based on our previous work. All compounds exhibited potent in vitro antifungal activities against seven pathogenic fungi. Among them, tetrazole compound D2 was the most potent antifungal with MIC values of <0.008, <0.008, and 2 μg/mL against Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus, respectively, the three most common and critical priority pathogenic fungi. In addition, compound D2 also exhibited potent activity against fluconazole-resistant C. auris isolates. Notably, compound D2 showed a lower inhibitory activity in vitro against human CYP450 enzymes as well as a lower inhibitory effect on the hERG K+ channel, indicating a low risk of drug-drug interactions and QT prolongation. Moreover, with improved pharmacokinetic profiles, compound D2 showed better in vivo efficacy than albaconazole at reducing fungal burden and extending the survival of C. albicans-infected mice. Taken together, compound D2 will be further investigated as a promising candidate.
Collapse
Affiliation(s)
- Tingjunhong Ni
- Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, No. 1239 Siping Road ,Shanghai 200092, China
| | - Yumeng Hao
- School of Pharmacy, Naval Medical University, No. 325 Guohe Road, Shanghai 200433, China
| | - Zichao Ding
- School of Pharmacy, Naval Medical University, No. 325 Guohe Road, Shanghai 200433, China
- Department of Pharmacy, 927th Hospital of Joint Logistics Support Force, 3 Yushui Road ,Puer 665000, China
| | - Xiaochen Chi
- School of Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Fei Xie
- School of Pharmacy, Naval Medical University, No. 325 Guohe Road, Shanghai 200433, China
| | - Ruina Wang
- School of Pharmacy, Naval Medical University, No. 325 Guohe Road, Shanghai 200433, China
| | - Junhe Bao
- School of Pharmacy, Naval Medical University, No. 325 Guohe Road, Shanghai 200433, China
| | - Lan Yan
- School of Pharmacy, Naval Medical University, No. 325 Guohe Road, Shanghai 200433, China
| | - Liping Li
- Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, No. 1239 Siping Road ,Shanghai 200092, China
| | - Ting Wang
- School of Pharmacy, Naval Medical University, No. 325 Guohe Road, Shanghai 200433, China
| | - Dazhi Zhang
- Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, No. 1239 Siping Road ,Shanghai 200092, China
- School of Pharmacy, Naval Medical University, No. 325 Guohe Road, Shanghai 200433, China
| | - Yuanying Jiang
- Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, No. 1239 Siping Road ,Shanghai 200092, China
| |
Collapse
|
2
|
Tang Y, Li Z, Zeng M, Li R, Song H, Zhang D, Xue F, Qin Y. Asymmetric Synthesis of Triazole Antifungal Agents Enabled by an Upgraded Strategy for the Key Epoxide Intermediate. J Org Chem 2024; 89:4971-4978. [PMID: 38509452 DOI: 10.1021/acs.joc.4c00193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/22/2024]
Abstract
A streamlined and efficient approach to the key epoxide intermediate for the asymmetric synthesis of triazole antifungal agents is presented. This synthesis highlights a P(NMe2)3-mediated nonylidic olefination of α-keto ester, ensuring the exclusive formation of the requisite (Z)-alkene, followed by a highly enantioselective Jacobsen epoxidation to establish the two vicinal stereocenters in a single step. The versatility of this strategy is exemplified through the efficient synthesis of efinaconazole and ravuconazole.
Collapse
Affiliation(s)
- Yu Tang
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China
| | - Zhuo Li
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China
| | - Meiqi Zeng
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China
| | - Ran Li
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China
| | - Hao Song
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China
| | - Dan Zhang
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China
| | - Fei Xue
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China
| | - Yong Qin
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China
| |
Collapse
|
3
|
Ju Z, Li Z, Li M, Xu S, Kaliaperumal K, Chen FE. A Chemo-Enzymatic Approach for Preparing Efinaconazole with High Optical Yield. J Org Chem 2023; 88:14803-14808. [PMID: 37792295 DOI: 10.1021/acs.joc.3c01641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/05/2023]
Abstract
Herein, we present a novel and ecofriendly biocatalytic approach for synthesizing efinaconazole (7), a clinically used antifungal agent. This method involves utilizing benzaldehyde lyase (BAL) to catalyze the crucial benzoin condensation step in the ketone precursor. Treating 2,4-difluorobenzaldehyde with BAL in the presence of thiamin-diphosphate (ThDP) and Mg2+ resulted in the formation of α-hydroxy ketone which then underwent the preparation of 7. This innovative approach not only provides a greener alternative but also offers significant advantages over the traditional chemical process. Through our efforts and development work, we have established efficient and scalable procedures that enable the production of 7 in a moderate 38% yield.
Collapse
Affiliation(s)
- Zhiran Ju
- Institute of Pharmaceutical Science and Technology, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China
| | - Zhiyun Li
- Institute of Pharmaceutical Science and Technology, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China
| | - Menglan Li
- Institute of Pharmaceutical Science and Technology, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China
| | - Saili Xu
- Institute of Pharmaceutical Science and Technology, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China
| | | | - Fen-Er Chen
- Institute of Pharmaceutical Science and Technology, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China
- Engineering Center of Catalysis and Synthesis for Chiral Molecules, Fudan University, Shanghai 200433, China
- Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs, Shanghai 200433, China
| |
Collapse
|
4
|
Asymmetric Synthesis of US-FDA Approved Drugs over Five Years (2016–2020): A Recapitulation of Chirality. Pharmaceuticals (Basel) 2023; 16:ph16030339. [PMID: 36986439 PMCID: PMC10052577 DOI: 10.3390/ph16030339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2022] [Revised: 02/09/2023] [Accepted: 02/17/2023] [Indexed: 02/25/2023] Open
Abstract
Chirality is a major theme in the design, discovery, and development of new drugs. Historically, pharmaceuticals have been synthesized as racemic mixtures. However, the enantiomeric forms of drug molecules have distinct biological properties. One enantiomer may be responsible for the desired therapeutic effect (eutomer), whereas the other may be inactive, interfere with the therapeutic form, or exhibit toxicity (distomer). Classical chemical synthesis usually leads to a racemic mixture unless stereospecific synthesis is employed. To meet the requirements of single-enantiomeric drugs, asymmetric synthesis has evolved at the forefront of drug discovery. Asymmetric synthesis involves the conversion of an achiral starting material into a chiral product. This review emphasizes the methods used for synthesizing FDA-approved chiral drugs during 2016–2020, with a special focus on asymmetric synthesis by means of chiral induction, resolution, or chiral pool.
Collapse
|
5
|
Samineni R, Eda V, Rao P, Sen S, Oruganti S. Grignard Reagents as Niche Bases in the Synthesis of Pharmaceutically Relevant Molecules. ChemistrySelect 2022. [DOI: 10.1002/slct.202102853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Ramesh Samineni
- Center for Innovation in Molecular and Pharmaceutical Sciences (CIMPS) Dr. Reddy's Institute of Life Sciences University of Hyderabad campus, Gachibowli Hyderabad 500046 India
| | - Vishnuvardhana Eda
- Center for Process Research and Innovation (CPRI) Dr. Reddy's Institute of Life Sciences University of Hyderabad campus, Gachibowli Hyderabad 500046 India
| | - Pallavi Rao
- Center for Process Research and Innovation (CPRI) Dr. Reddy's Institute of Life Sciences University of Hyderabad campus, Gachibowli Hyderabad 500046 India
| | - Saikat Sen
- Center for Process Research and Innovation (CPRI) Dr. Reddy's Institute of Life Sciences University of Hyderabad campus, Gachibowli Hyderabad 500046 India
| | - Srinivas Oruganti
- Center for Process Research and Innovation (CPRI) Dr. Reddy's Institute of Life Sciences University of Hyderabad campus, Gachibowli Hyderabad 500046 India
| |
Collapse
|
6
|
Gerzon G, Sheng Y, Kirkitadze M. Process Analytical Technologies - Advances in bioprocess integration and future perspectives. J Pharm Biomed Anal 2022; 207:114379. [PMID: 34607168 DOI: 10.1016/j.jpba.2021.114379] [Citation(s) in RCA: 21] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Revised: 09/12/2021] [Accepted: 09/15/2021] [Indexed: 12/22/2022]
Abstract
Process Analytical Technology (PAT) instruments include analyzers capable of measuring physical and chemical process parameters and key attributes with the goal of optimizing process controls. PAT in the form of a probe or sensor is designed to integrate within the pharmaceutical manufacturing line and is coupled with computing equipment to perform chemometric modeling for result interpretation and multilayer statistical control of processes. PAT solutions are intended for understanding bioprocesses with a goal to control quality at all stages of product manufacturing and achieve quality by design (QbD). The goal of PAT implementation is to promote real-time release of products to decrease the cycle time and cost of production. This review focuses on the applications of PAT solutions at different stages of the manufacturing process for vaccine production, the advantages, challenges at present state, and the vision of the future development of biopharmaceutical industries.
Collapse
Affiliation(s)
- Gabriella Gerzon
- Department of Biology, Faculty of Science, York University, Toronto, Canada; Analytical Sciences, Sanofi Pasteur, Toronto, Canada
| | - Yi Sheng
- Department of Biology, Faculty of Science, York University, Toronto, Canada
| | | |
Collapse
|
7
|
Ghobadi E, Saednia S, Emami S. Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development. Eur J Med Chem 2022; 231:114161. [DOI: 10.1016/j.ejmech.2022.114161] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2021] [Revised: 01/24/2022] [Accepted: 01/25/2022] [Indexed: 12/24/2022]
|
8
|
He Q, Zhang D, Zhang F, Liu X, Feng X. Asymmetric Catalytic Epoxidation of Terminal Enones for the Synthesis of Triazole Antifungal Agents. Org Lett 2021; 23:6961-6966. [PMID: 34424719 DOI: 10.1021/acs.orglett.1c02588] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
An enantioselective epoxidation of α-substituted vinyl ketones was realized to construct the key epoxide intermediates for the synthesis of various triazole antifungal agents. The reaction proceeded efficiently in high yields with good enantioselectivities by employing a chiral N,N'-dioxide/ScIII complex as the chiral catalyst and 35% aq. H2O2 as the oxidant. It enabled the facile transformation for optically active isavuconazole, efinaconazole, and other potential antifungal agents.
Collapse
Affiliation(s)
- Qianwen He
- Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China
| | - Dong Zhang
- Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China
| | - Fengcai Zhang
- Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China
| | - Xiaohua Liu
- Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China
| | - Xiaoming Feng
- Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China
| |
Collapse
|
9
|
Abstract
This review concentrates on success stories from the synthesis of approved medicines and drug candidates using epoxide chemistry in the development of robust and efficient syntheses at large scale. The focus is on those parts of each synthesis related to the substrate-controlled/diastereoselective and catalytic asymmetric synthesis of epoxide intermediates and their subsequent ring-opening reactions with various nucleophiles. These are described in the form of case studies of high profile pharmaceuticals spanning a diverse range of indications and molecular scaffolds such as heterocycles, terpenes, steroids, peptidomimetics, alkaloids and main stream small molecules. Representative examples include, but are not limited to the antihypertensive diltiazem, the antidepressant reboxetine, the HIV protease inhibitors atazanavir and indinavir, efinaconazole and related triazole antifungals, tasimelteon for sleep disorders, the anticancer agent carfilzomib, the anticoagulant rivaroxaban the antibiotic linezolid and the antiviral oseltamivir. Emphasis is given on aspects of catalytic asymmetric epoxidation employing metals with chiral ligands particularly with the Sharpless and Jacobsen–Katsuki methods as well as organocatalysts such as the chiral ketones of Shi and Yang, Pages’s chiral iminium salts and typical chiral phase transfer agents.
Collapse
|
10
|
Xie F, Ni T, Ding Z, Hao Y, Wang R, Wang R, Wang T, Chai X, Yu S, Jin Y, Jiang Y, Zhang D. Design, synthesis, and in vitro evaluation of novel triazole analogues featuring isoxazole moieties as antifungal agents. Bioorg Chem 2020; 101:103982. [DOI: 10.1016/j.bioorg.2020.103982] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2019] [Revised: 05/23/2020] [Accepted: 05/29/2020] [Indexed: 01/17/2023]
|
11
|
Flick AC, Leverett CA, Ding HX, McInturff E, Fink SJ, Helal CJ, DeForest JC, Morse PD, Mahapatra S, O’Donnell CJ. Synthetic Approaches to New Drugs Approved during 2018. J Med Chem 2020; 63:10652-10704. [DOI: 10.1021/acs.jmedchem.0c00345] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- Andrew C. Flick
- Takeda California, Inc., 9625 Towne Centre Drive, San Diego, California 92121, United States
| | - Carolyn A. Leverett
- Groton Laboratories, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Hong X. Ding
- Pharmacodia (Beijing) Co., Ltd., Beijing 100085, China
| | - Emma McInturff
- Groton Laboratories, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Sarah J. Fink
- Takeda Pharmaceutical Company Limited, 125 Binney Street, Cambridge, Massachusetts 02142, United States
| | | | - Jacob C. DeForest
- Groton Laboratories, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Peter D. Morse
- Groton Laboratories, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Subham Mahapatra
- Groton Laboratories, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Christopher J. O’Donnell
- Groton Laboratories, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States
| |
Collapse
|
12
|
Design, synthesis, and structure-activity relationship studies of novel triazole agents with strong antifungal activity against Aspergillus fumigatus. Bioorg Med Chem Lett 2020; 30:126951. [DOI: 10.1016/j.bmcl.2020.126951] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2019] [Revised: 12/26/2019] [Accepted: 01/01/2020] [Indexed: 11/22/2022]
|
13
|
Ryan SJ, Yang Q. Development of a Practical Synthesis of a Pyrimidine Derivative with Fungicidal Activity. Org Process Res Dev 2019. [DOI: 10.1021/acs.oprd.9b00130] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Sarah J. Ryan
- Product Design & Process R&D, Corteva Agriscience, 9330 Zionsville Road, Indianapolis, Indiana 46268, United States
| | - Qiang Yang
- Product Design & Process R&D, Corteva Agriscience, 9330 Zionsville Road, Indianapolis, Indiana 46268, United States
| |
Collapse
|
14
|
Zheng Y, Qian A, Ling C, Cao X, Cui Y, Yang Y. Improved Laboratory Synthesis of YC-071, a Potent Azole Antifungal Agent. JOURNAL OF CHEMICAL RESEARCH 2017. [DOI: 10.3184/174751917x14902201357419] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
An improved laboratory synthesis of YC-071, a potent azole antifungal agent, has been developed. Compared with the original route, the new route is operationally simple, requiring only limited purification of all the intermediates. The new route is an important scalable synthesis, which meets the need for YC-071 for use in preclinical studies.
Collapse
Affiliation(s)
- Yazhou Zheng
- Department of Chemistry, College of Sciences, Shanghai University, Shanghai 200444, P.R. China
| | - Anran Qian
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China
- University of Chinese Academy of Sciences, Beijing 100049, P.R. China
| | - Chenyu Ling
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China
- University of Chinese Academy of Sciences, Beijing 100049, P.R. China
| | - Xufeng Cao
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China
- University of Chinese Academy of Sciences, Beijing 100049, P.R. China
| | - YongMei Cui
- Department of Chemistry, College of Sciences, Shanghai University, Shanghai 200444, P.R. China
| | - Yushe Yang
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China
- University of Chinese Academy of Sciences, Beijing 100049, P.R. China
| |
Collapse
|
15
|
Dunetz JR, Magano J, Weisenburger GA. Large-Scale Applications of Amide Coupling Reagents for the Synthesis of Pharmaceuticals. Org Process Res Dev 2016. [DOI: 10.1021/op500305s] [Citation(s) in RCA: 411] [Impact Index Per Article: 51.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Joshua R. Dunetz
- Process
Chemistry, Gilead Sciences, 333 Lakeside Drive, Foster City, California 94404, United States
| | - Javier Magano
- Chemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Gerald A. Weisenburger
- Chemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| |
Collapse
|
16
|
Cao X, Xu Y, Cao Y, Wang R, Zhou R, Chu W, Yang Y. Design, synthesis, and structure-activity relationship studies of novel thienopyrrolidone derivatives with strong antifungal activity against Aspergillus fumigates. Eur J Med Chem 2015; 102:471-6. [PMID: 26310892 DOI: 10.1016/j.ejmech.2015.08.023] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2015] [Revised: 08/06/2015] [Accepted: 08/09/2015] [Indexed: 11/16/2022]
Abstract
In order to further enhance the anti-Aspergillus efficacy of our previously discovered antifungal lead compounds (I), two series of novel azoles featuring thieno[2,3-c]pyrrolidone and thieno[3,2-c]pyrrolidone nuclei were designed and evaluated for their in vitro activity on the basis of the binding mode of albaconazole using molecular docking, along with SARs of antifungal triazoles. Most of target compounds exhibited excellent activity against Candida and Cryptococcus spp., with MIC values in the range of 0.0625 μg/ml to 0.0156 μg/ml. The thieno[3,2-c]pyrrolidone unit was more suited for improving activity against Aspergillus spp. The most potent compound, 18a, was selected for further development due to its significant in vitro activity against Aspergillus spp. (MIC = 0.25 μg/ml), as well as its high metabolic stability in human liver microsomes.
Collapse
Affiliation(s)
- Xufeng Cao
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, 555 Zuchong Zhi Road, Shanghai 201203, China
| | - Yuanyuan Xu
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, 555 Zuchong Zhi Road, Shanghai 201203, China
| | - Yongbing Cao
- School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China
| | - Ruilian Wang
- School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China
| | - Ran Zhou
- Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchong Zhi Road, Shanghai 201203, China
| | - Wenjing Chu
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, 555 Zuchong Zhi Road, Shanghai 201203, China
| | - Yushe Yang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, 555 Zuchong Zhi Road, Shanghai 201203, China.
| |
Collapse
|
17
|
Ding HX, Leverett CA, Kyne RE, Liu KKC, Fink SJ, Flick AC, O’Donnell CJ. Synthetic approaches to the 2013 new drugs. Bioorg Med Chem 2015; 23:1895-922. [DOI: 10.1016/j.bmc.2015.02.056] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2015] [Revised: 02/20/2015] [Accepted: 02/26/2015] [Indexed: 12/31/2022]
|
18
|
Tian Q, Hoffmann U, Humphries T, Cheng Z, Hidber P, Yajima H, Guillemot-Plass M, Li J, Bromberger U, Babu S, Askin D, Gosselin F. A Practical, Protecting-Group-Free Synthesis of a PI3K/mTOR Inhibitor. Org Process Res Dev 2015. [DOI: 10.1021/op500366s] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Qingping Tian
- Small Molecule
Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| | - Ursula Hoffmann
- Pharma Technical
Development PTDCA, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, CH-4070 Basel, Switzerland
| | - Theresa Humphries
- Small Molecule
Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| | - Zhigang Cheng
- Small Molecule
Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| | - Pirmin Hidber
- Pharma Technical
Development PTDCA, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, CH-4070 Basel, Switzerland
| | - Herbert Yajima
- Small Molecule
Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| | - Maud Guillemot-Plass
- Pharma Technical
Development PTDCA, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, CH-4070 Basel, Switzerland
| | - Jane Li
- Small Molecule
Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| | - Ulrike Bromberger
- Pharma Technical
Development PTDCA, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, CH-4070 Basel, Switzerland
| | - Srinivasan Babu
- Small Molecule
Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| | - David Askin
- Small Molecule
Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| | - Francis Gosselin
- Small Molecule
Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
| |
Collapse
|
19
|
Lobben PC, Barlow E, Bergum JS, Braem A, Chang SY, Gibson F, Kopp N, Lai C, LaPorte TL, Leahy DK, Müslehiddinoğlu J, Quiroz F, Skliar D, Spangler L, Srivastava S, Wasser D, Wasylyk J, Wethman R, Xu Z. Control Strategy for the Manufacture of Brivanib Alaninate, a Novel Pyrrolotriazine VEGFR/FGFR Inhibitor. Org Process Res Dev 2014. [DOI: 10.1021/op500126u] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Paul C. Lobben
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Evan Barlow
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - James S. Bergum
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Alan Braem
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Shih-Ying Chang
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Frank Gibson
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Nathaniel Kopp
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Chiajen Lai
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Thomas L. LaPorte
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - David K. Leahy
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Jale Müslehiddinoğlu
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Fernando Quiroz
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Dimitri Skliar
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Lori Spangler
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Sushil Srivastava
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Daniel Wasser
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - John Wasylyk
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Robert Wethman
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| | - Zhongmin Xu
- Chemical Development, Bristol-Myers Squibb Company, One Squibb
Drive, New Brunswick, New
Jersey 08903, United States
| |
Collapse
|
20
|
Tamura K, Kumagai N, Shibasaki M. An Enantioselective Synthesis of the Key Intermediate for Triazole Antifungal Agents; Application to the Catalytic Asymmetric Synthesis of Efinaconazole (Jublia). J Org Chem 2014; 79:3272-8. [DOI: 10.1021/jo500369y] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Keiji Tamura
- Institute of Microbial Chemistry (BIKAKEN), Tokyo, 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo 141-0021, Japan
| | - Naoya Kumagai
- Institute of Microbial Chemistry (BIKAKEN), Tokyo, 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo 141-0021, Japan
| | - Masakatsu Shibasaki
- Institute of Microbial Chemistry (BIKAKEN), Tokyo, 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo 141-0021, Japan
- ACT-C, Japan Science and Technology Agency (JST), 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo 141-0021, Japan
| |
Collapse
|
21
|
Cao X, Sun Z, Cao Y, Wang R, Cai T, Chu W, Hu W, Yang Y. Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility. J Med Chem 2014; 57:3687-706. [PMID: 24564525 DOI: 10.1021/jm4016284] [Citation(s) in RCA: 81] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Triazoles with fused-heterocycle nuclei were designed and evaluated for their in vitro activity on the basis of the binding mode of albaconazole using molecular docking, along with SAR of antifungal triazoles. Tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine and tetrahydro-thiazolo[5,4-c]pyridine nuclei were preferable to the other four fused-heterocycle nuclei investigated. Potent in vitro activity, broad spectrum and better water solubility were attained when triazoles containing nitrogen aromatic heterocycles were attached to these two nuclei. The most potent compounds 27aa and 45x, with low hERG inhibition and hepatocyte toxicity, both exhibited excellent activity against Candida, Cryptococcus, and Aspergillus spp., as well as selected fluconazole-resistant strains. A high water-soluble compound 58 (the disulfate salt of 45x) displayed unsatisfactory in vivo activity because of its poor PK profiles. Mice infected with C.alb. SC5314 and C.alb. 103 (fluconazole-resistant strain) and administered with 27aa displayed significantly improved survival rates. 27aa also showed favorable pharmacokinetic (PK) profiles.
Collapse
Affiliation(s)
- Xufeng Cao
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences , Shanghai 201203, China
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Boratyński PJ, Skarżewski J. Diastereoselective Corey–Chaykovsky 9-Epoxymethylation of Cinchona Alkaloids: Access to Chiral Scaffolds with Diverse Functionalities. J Org Chem 2013; 78:4473-82. [DOI: 10.1021/jo400465a] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Affiliation(s)
- Przemysław J. Boratyński
- Department of Organic Chemistry,
Faculty of Chemistry, Wrocław University of Technology, 50-370 Wrocław,
Poland
| | - Jacek Skarżewski
- Department of Organic Chemistry,
Faculty of Chemistry, Wrocław University of Technology, 50-370 Wrocław,
Poland
| |
Collapse
|
23
|
Cao XF, Chu WJ, Cao YB, Yang YS. Design and synthesis of novel antifungal triazole derivatives with good activity and water solubility. CHINESE CHEM LETT 2013. [DOI: 10.1016/j.cclet.2013.01.047] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
24
|
Lo E, Mattas E, Wei C, Kacsur D, Chen CK. Simultaneous API Particle Size Reduction and Polymorph Transformation Using High Shear. Org Process Res Dev 2012. [DOI: 10.1021/op2002529] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Ehrlic Lo
- Bristol-Myers Squibb Company, Chemical Development, One Squibb Drive, New
Brunswick, New Jersey 08903-0191, United States
| | - Elias Mattas
- Bristol-Myers Squibb Company, Chemical Development, One Squibb Drive, New
Brunswick, New Jersey 08903-0191, United States
| | - Chenkou Wei
- Bristol-Myers Squibb Company, Chemical Development, One Squibb Drive, New
Brunswick, New Jersey 08903-0191, United States
| | - David Kacsur
- Bristol-Myers Squibb Company, Chemical Development, One Squibb Drive, New
Brunswick, New Jersey 08903-0191, United States
| | - Chien-Kuang Chen
- Bristol-Myers Squibb Company, Chemical Development, One Squibb Drive, New
Brunswick, New Jersey 08903-0191, United States
| |
Collapse
|
25
|
|
26
|
|